Zobrazeno 1 - 10
of 2 367
pro vyhledávání: '"Guo, Mei"'
Autor:
Xu, Qi1 (AUTHOR) xuqi8270@sina.com, Guo, Mei1 (AUTHOR) mguo@qlu.edu.cn, Wang, Haidi1 (AUTHOR) 15689476503@163.com, Liu, Haitao1 (AUTHOR) 19863823759@163.com, Wei, Yunbo1 (AUTHOR) weiyunbo0211@126.com, Wang, Xiao1 (AUTHOR) wangx@sdas.org, Mackay, Charles R.1,2 (AUTHOR) c.mackay@me.com, Wang, Quanbo1 (AUTHOR) qbwang@qlu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9420. 19p.
Autor:
Zhang, Qian, Zhang, Yuanlv, Li, Xiaoxue, Cao, Qingqing, Ma, Fang, Li, Yang, Xie, Delang, Ma, Haiyang, Zhang, Bingbing, Li, Xiaojun, Feng, Yuqin, Guo, Jiajun, Guo, Mei, Liu, Guishan
Publikováno v:
In International Journal of Biological Macromolecules November 2024 281 Part 1
Autor:
Zhang, Na, Guo, Jianghong, Zhang, Mengya, Yu, Yingmei, Guo, Mei, Xu, Hao, Wang, Zhendong, Wu, Linliang, Wang, Xiaofeng, Jiang, Xiaoyan
Publikováno v:
In Geriatric Nursing November-December 2024 60:150-155
Autor:
Zhang, Yuanlv, Li, Yang, Guo, Jiajun, Feng, Yuqin, Xie, Qiwen, Guo, Mei, Yin, Junjie, Liu, Guishan
Publikováno v:
In Food Chemistry 30 October 2024 456
Autor:
Ren, Yue, Wang, Yilin, Zhang, Yuxin, Yang, Zhongshuai, Ma, Zhiming, Chen, Jiaxin, Chen, Xintong, Qiu, Zecheng, Tian, Jing, Pu, Aofei, Yin, Junjie, Guo, Mei, Song, Yating, Guo, Jiajun, Feng, Yuqin, Liu, Guishan
Publikováno v:
In Trends in Food Science & Technology October 2024 152
Publikováno v:
In Journal of Energy Storage 15 September 2024 98 Part A
Autor:
Qiu, Zecheng, Chen, Xintong, Xie, Delang, Ren, Yue, Wang, Yilin, Yang, Zhongshuai, Guo, Mei, Song, Yating, Guo, Jiajun, Feng, Yuqin, Kang, Ningbo, Liu, Guishan
Publikováno v:
In Trends in Food Science & Technology January 2025 155
Publikováno v:
In Journal of Food Composition and Analysis January 2025 137 Part A
Autor:
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 227-237 (2024)
Abstract Introduction Currently, the cause of psoriatic arthritis (PsA) is unknown, and the effectiveness of current drug treatments is unsatisfactory. In March 2019, the US Food and Drug Administration (FDA) approved risankizumab, a humanized immuno
Externí odkaz:
https://doaj.org/article/02e8c4b1e856444593e5ab8c9f52f166
Publikováno v:
In International Immunopharmacology 25 December 2024 143 Part 1